Literature DB >> 12202848

Relationship between the Minnesota Living With Heart Failure Questionnaire and key ventilatory expired gas measures during exercise testing in patients with heart failure.

Ross Arena1, Reed Humphrey, Mary Ann Peberdy.   

Abstract

PURPOSE: This study assessed the relationship between the Minnesota Living With Heart Failure Questionnaire (MLWHFQ) and key ventilatory expired gas measures during a symptom-limited exercise test in the heart failure (HF) population. Specifically, is there evidence to indicate that perceived quality of life (QOL) influences exercise performance independent of physiologic function in the HF population?
METHODS: Thirty-one subjects (21 male/10 female), diagnosed with compensated HF, underwent exercise testing and completed the MLWHFQ. Mean age and left ventricular ejection fraction were 52.8 years and 27.2%, respectively. Partial correlation, controlling for age and sex, assessed the relationship between MLWHFQ (overall and subscores) and key ventilatory expired gas measures. Intraclass correlation coefficient (ICC) analysis was used to determine reliability of the MLWHFQ.
RESULTS: MLWHQ overall score (mean = 38.9, median = 36.0), physical subscore (mean = 14.8, median = 16.0), and psychosocial/symptomatology subscore (mean = 24.1, median = 19.0), were significantly correlated (P < or =.05) with peak oxygen consumption (VO2). The relationship between MLWHFQ and the minute ventilation-carbon dioxide production (VE/VCO2) slope was, however, not significant. ICC analysis revealed high reliability (0.95) for the MLWHFQ.
CONCLUSIONS: The MLWHFQ demonstrates a significant relationship with peak VO2, a measure whose validity is dependent upon subject effort. VE/VCO2 slope, which is independent of subject effort and therefore potentially a better predictor of true physiologic function, does not appear to have a relationship with perceived QOL. These findings have implications for how the MLWHFQ is assessed, related to an exercise test, and used during clinical practice.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12202848     DOI: 10.1097/00008483-200207000-00010

Source DB:  PubMed          Journal:  J Cardiopulm Rehabil        ISSN: 0883-9212            Impact factor:   2.081


  5 in total

1.  Exercise oscillatory ventilation reflects diminished quality of life and perceived functional capacity in patients with heart failure.

Authors:  Ross Arena; Marco Guazzi; Jonathan Myers; Paul Chase; Daniel Bensimhon; Larry Cahalin; Mary Ann Peberdy; Euan Ashley; Erin West; Daniel E Forman
Journal:  Int J Cardiol       Date:  2011-10-10       Impact factor: 4.164

2.  Clinical predictors of response to anakinra in patients with heart failure.

Authors:  Justin M Canada; Benjamin W Van Tassell; Sanah Christopher; Claudia Oddi; Nayef A Abouzaki; Michael L Gambill; George Mueller; Ryan Melchior; Keyur B Shah; Charles A Dinarello; Antonio Abbate; Ross Arena
Journal:  Int J Cardiol       Date:  2014-03-15       Impact factor: 4.164

3.  IL-1 Blockade in Patients With Heart Failure With Preserved Ejection Fraction.

Authors:  Benjamin W Van Tassell; Cory R Trankle; Justin M Canada; Salvatore Carbone; Leo Buckley; Dinesh Kadariya; Marco G Del Buono; Hayley Billingsley; George Wohlford; Michele Viscusi; Claudia Oddi-Erdle; Nayef A Abouzaki; Dave Dixon; Giuseppe Biondi-Zoccai; Ross Arena; Antonio Abbate
Journal:  Circ Heart Fail       Date:  2018-08       Impact factor: 8.790

4.  Factors related to time to admission to specialized multidisciplinary clinics in patients with congestive heart failure.

Authors:  Debbie Ehrmann Feldman; Anique Ducharme; Marc Frenette; Nadia Giannetti; Caroline Michel; François Grondin; Richard Sheppard; Hassan Behlouli; Louise Pilote
Journal:  Can J Cardiol       Date:  2009-10       Impact factor: 5.223

5.  Effects of interleukin-1 blockade with anakinra on aerobic exercise capacity in patients with heart failure and preserved ejection fraction (from the D-HART pilot study).

Authors:  Benjamin Wallace Van Tassell; Ross Arena; Giuseppe Biondi-Zoccai; Justin McNair Canada; Claudia Oddi; Nayef Antar Abouzaki; Arehzo Jahangiri; Raquel Appa Falcao; Michael Christopher Kontos; Keyur Bharat Shah; Norbert Felix Voelkel; Charles Anthony Dinarello; Antonio Abbate
Journal:  Am J Cardiol       Date:  2013-10-04       Impact factor: 2.778

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.